WallStreetZenWallStreetZen

NYSEMKT: AIM
Aim Immunotech Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aim Immunotech earnings were -$14.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest AIM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.8M, up 25.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIM reported annual earnings of -$14.0M, with -19.4% growth. The next AIM earnings date is Nov 16, 2026.

AIM earnings history

Current Revenue
$95.0k
Current Earnings
-$14.3M
Current Profit Margin
-15,021.1%

AIM Return on Equity

Current Company
N/A
Current Industry
-10.8%
Current Market
30.9%

AIM Return on Assets

Current Company
-175.1%
Current Industry
-10.7%
AIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AIM announces earnings.

AIM Return on Capital Employed

Current Company
-168.68%
Current Industry
-7.4%
AIM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AIM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AIM-$12.25M-$14.27MN/A-$3.13
EVGN-$3.57M-$9.07MN/A-$0.89
IMNN-$13.97M-$14.73MN/A-$3.84
CDIO-$6.08M-$6.47MN/A-$2.92
XBIO-$2.48M-$2.48MN/A-$1.16
View Top Biotech Stocks

AIM earnings dates

Next earnings date
Nov 16, 2026

Aim Immunotech Earnings Reports & History FAQ

What were Aim Immunotech's earnings last quarter?

On AIM's earnings call on Aug 13, 2026, Aim Immunotech (NYSEMKT: AIM) reported Q2 2026 earnings per share (EPS) of -$0.43, up 88.32% year over year. Total AIM earnings for the quarter were -$3.79 million. In the same quarter last year, Aim Immunotech's earnings per share (EPS) was -$3.68.

If you're new to stock investing, here's how to buy Aim Immunotech stock.

When does Aim Immunotech report earnings?

The next AIM earnings date is Nov 16, 2026. Add AIM to your watchlist to be reminded of Aim Immunotech's next earnings date.

Is Aim Immunotech profitable or losing money?

As of the last Aim Immunotech earnings report, Aim Immunotech is currently losing money. Aim Immunotech's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$14.27 million, a 11.73% decrease year over year.

What was AIM's earnings growth in the past year?

As of Aim Immunotech's earnings date in Aug 13, 2026, Aim Immunotech's earnings has grown year over year. AIM earnings in the past year totalled -$14.27 million.

What are Aim Immunotech's earnings expectations?

The current EPS estimate for Aim Immunotech's earnings report in Nov 16, 2026 is -$0.09.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.